The Enzyme That Dissolves Filler: Separating Fear from Fact
Let me tell you a story about an enzyme. Not just any enzyme, but one that has sparked fierce debate, online outrage, and genuine fear among patients and practitioners alike. It’s called hyaluronidase, and it has a reputation that is both life-saving and, for some, terrifying.
To understand the controversy, we must first appreciate what an enzyme truly is. Enzymes are not blunt chemical hammers; they are exquisitely precise, three-dimensional proteins—biological locks designed to fit only one specific key. Our bodies contain over 75,000 of these specialized workers, each performing just one reaction. Hyaluronidase’s job is to take a water molecule and break it down at a single type of chemical bond, the beta 1,4 bond, found only in hyaluronic acid. This specificity is crucial. An enzyme does not react with anything else; if it did, our bodies would collapse into chaos.
Interestingly, we all produce this enzyme naturally. Without it, our lymphatic systems would clog with hyaluronic acid, unable to drain fluids. Even the miracle of conception relies on it—sperm use hyaluronidase to dissolve the final hyaluronic barrier before new life begins. For decades, doctors have used animal-derived versions (from sheep, sheep, pigs, or cows) to help disperse drugs, break down hematomas, and, most famously, dissolve dermal filler. Today, we also have a synthetic human version, even more compatible and safer.
So why the fear? The story begins with a video titled “Filler Dissolver Destroyed My Face,” published by Dr. Gavin Chan and colleagues. It’s a provocative headline, but beneath it lies a nuanced discussion we must explore fully. The central problem is this: patient satisfaction with hyaluronidase reversals is notably low—around 50% on RealSelf at the time, compared to 94% satisfaction for the filler itself. That gap demands an explanation.
Why We Need This Enzyme in the First Place
First, let’s understand why hyaluronidase is necessary. Dr. Chan presented a case of filler-induced blindness that was successfully reversed with the enzyme—the most dramatic indication. Dr. Harris added that reversing overfilling is becoming more common, which matches my own clinical perception. We have been injecting high volumes of filler for 10 to 20 years, at scale. Alongside this, migration is a growing problem. Some filler does not stay put; it diffuses, attracts water, and degrades the appearance over time. Worse, the typical response to lost definition is to add more filler—probably the worst long-term strategy. We also know, from Dr. Master’s studies, that some filler can last up to 12 years. Waiting it out is not always an option. Dr. Kami Parsa even raised the possibility that lymphatics may become blocked, especially in the tear trough—a theory supported by animal studies where the hyaluronidase gene was knocked out. The simple truth is: as long as we use hyaluronic acid, we will need hyaluronidase.
The Controversial Claim: Does Hyaluronidase Damage the SMAS?
The most thought-provoking point in the video came from Dr. Ben Talei, a surgeon who shared his experience from over 3,000 surgical lip lifts. He noticed that in some patients who had previously undergone filler reversal, the SMAS—the superficial musculoaponeurotic system, a layer of connective tissue in the face—appeared thinner, less able to hold moisture. He reported that injected saline did not seem to stay as it would in normal tissue; the SMAS lost its puffy nature. He speculated that hyaluronidase might be depleting the SMAS, and he concluded that it could have a lifelong effect.
This is a hypothesis worth taking seriously, but we must be careful not to mistake it for proven fact. Let me explain why we cannot draw a causal relationship from this observation alone. First, it is not a structured study with data to interrogate—it is personal experience, which is the lowest form of evidence. Second, these were all patients having surgical lip lifts, which introduces selection bias. How can we be sure these patients didn’t have a weaker SMAS already, causing them to seek lip filler in the first place, and then have reversals to prepare for surgery? Third, there is confirmation bias: when we believe a theory, we tend to notice cases that support it and overlook those that don’t. A surgeon who expects a thinner SMAS in reversal patients will mentally record that correlation and ignore the many patients who had hyaluronidase and still had a normal SMAS.
Let me challenge the theory further. Even if a correlation existed, the mechanism might not be the enzyme itself. What if long-term use of hyaluronic acid filler causes the body to downregulate its own natural production of hyaluronic acid? When you then dissolve the filler, you are left with less extracellular matrix—exactly the same clinical picture of volume loss and tissue thinning—without the enzyme being at fault. This is the difficulty with hypotheses presented as conclusions: they are easy to come up with and hard to disprove. They can spread as memes for years before the truth catches up.
What the Evidence Actually Shows
Reassuringly, the video also included Dr. Gabriela Casabona’s experiment. She injected hyaluronidase and measured the skin’s resistance to a pinch test. The result was a dose-dependent decrease in resistance that lasted only 48 hours, after which it returned completely to baseline. This suggests that hyaluronidase breaks down natural hyaluronic acid in the skin, but the body quickly remanufactures it. Within two days, the tissue is back to normal.
So if the physical structure recovers so quickly, why are some patients deeply unhappy after reversal? We need to tease out the possibilities, which fall into three categories: perceptual changes, real physical changes, or a combination. One theory is that filler has stretched the tissue, and when dissolved, the skin is now worse than before. I think this is unlikely unless extremely large volumes were used. Another theory is acclimatization: a patient becomes accustomed to an overfilled state, and returning to a normal volume feels like a terrible loss. The shock of losing volume so quickly can shift perception permanently. A third possibility is that hyaluronidase really does damage the SMAS in a few unlucky individuals—but as we discussed, that remains unproven.
There is also a psychological dimension. Patients who seek reversal are often those who are dissatisfied with their appearance, and dissatisfaction is a hallmark of body dysmorphic disorder. These individuals are more likely to be traumatized by small changes and to persist in an unhappy state. Also, there is the nocebo effect: when a patient expects the worst, they tend to notice and amplify every negative sensation while ignoring positives. With online communities reinforcing these fears, I would caution any clinician against treating a patient who already believes that hyaluronidase dissolves normal tissue. That level of certainty is a red flag.
In fact, some of the RealSelf testimonials from dissatisfied patients actually mention body dysmorphia themselves. Regardless of any long-term physical effect, such patients are overrepresented in these experiences simply because having a reversal often means you were significantly unhappy with the previous treatment.
A Wise Approach for Clinicians and Patients
So what should you do when a patient raises concerns about hyaluronidase? First, adhere to a fundamental medical principle: intervene with discretion. We should not be gung-ho with anything we inject. We are not omniscient, and it is possible that new evidence could emerge showing long-term effects in a few cases. I haven’t seen convincing evidence yet, but I act as if it could be true. That means I don’t dismiss the fear.
Second, in every consultation, dive into the patient’s health beliefs. Let them talk about everything they have read. Never dismiss their fears. Then, systematically share your understanding. If their beliefs are incompatible with the treatment—if they firmly believe hyaluronidase will cause their face to collapse—do not offer it. An anxious patient with self-loathing, a history of dissatisfaction with prior treatments, and a deep fear of hyalase should be handled with extreme caution, erring on the side of no treatment at all.
I should state for transparency: I am an independent doctor. Unlike many high-profile voices in this space, I am not a paid representative of any drug manufacturer or pharmacy company. I make my income by educating practitioners about complications. So it is not in my interest to minimize this issue. My philosophy is simple: seek the truth, shed light, and foster open discussion—even when we disagree. That is how we best serve patients.
I thank Dr. Chan and his colleagues for a video that truly gets us thinking. It has shed light on a deeply important issue. I will continue to gather information and may change my mind entirely as new evidence emerges. But for now, the story of hyaluronidase remains one of precision, possibility, and the need for cautious, compassionate conversation.